Selective impairment of pancreatic A cell suppression by glucose during acute alloxan-induced insulinopenia: in vitro study on isolated perfused rat pancreas

• Published in: Endocrinology (Philadelphia) Vol. 119; no. 1; p. 408
• Main Authors: Filipponi, P, Gregorio, F, Cristallini, S, Ferrandina, C, Nicoletti, I, Santeusanio, F
• Format: Journal Article
• Language: English
• Published: United States 01.07.1986
• Subjects: Alloxan - toxicity; Animals; Arginine - pharmacology; Diabetes Mellitus, Experimental - chemically induced; Diabetes Mellitus, Experimental - physiopathology; Glucagon - metabolism; Glucose - pharmacology; Insulin - metabolism; Insulin - pharmacology; Insulin Secretion; Islets of Langerhans - drug effects; Islets of Langerhans - metabolism; Male; Perfusion; Rats; Rats, Inbred Strains
• DOI: 10.1210/endo-119-1-408
• ISSN: 0013-7227

This study was performed in order to investigate the role of insulin in the modulation of pancreatic A cell response to glucose. The isolated perfused rat pancreas model was used: intraislet insulinopenia was induced in vitro by 0.56 mM alloxan infusion over 15 min. Alloxan caused a transitory insulin release but did not affect glucagon secretion. Exposure to alloxan completely abolished insulin response to 20 mM arginine, 1.6 mM glucose, and 11.1 mM glucose. Glucagon response to 20 mM arginine and 1.6 mM glucose was unchanged by alloxan pretreatment compared to control pancreata not treated with alloxan. However, the suppression of glucagon release by 11.1 mM glucose was abolished in the alloxan experiments. Twenty milliunits per ml of insulin infused during 11.1 mM glucose infusion restored glycemic suppression of glucagon release, but it produced only a slight inhibitory effect on A cell function in the presence of 3.9 mM glucose. Our study indicates that glucose is the physiological suppressor of the pancreatic A cell and that, in this regard, insulin exerts only a permissive effect.